Antiepileptic drug therapy: does mechanism of action matter?

Brodie, M. J., Covanis, A., Gil-Nagel, A., Lerche, H., Perucca, E., Sills, G. J. and White, H. S. (2011) Antiepileptic drug therapy: does mechanism of action matter? Epilepsy and Behavior, 21(4), pp. 331-341. (doi:10.1016/j.yebeh.2011.05.025) (PMID:21763207)

Full text not currently available from Enlighten.

Abstract

This article represents a synthesis of presentations made by the authors during a scientific meeting held in London on 7 June 2010 and organized by GlaxoSmithKline. Each speaker produced a short précis of his lecture to answer a specific question, resulting in an overview of what we know about the relevance of the mechanisms of action of antiepileptic drugs in determining appropriate combination therapies for the treatment of drug-resistant epilepsy.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Sills, Dr Graeme
Authors: Brodie, M. J., Covanis, A., Gil-Nagel, A., Lerche, H., Perucca, E., Sills, G. J., and White, H. S.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Epilepsy and Behavior
Publisher:Elsevier
ISSN:1525-5050
ISSN (Online):1525-5069

University Staff: Request a correction | Enlighten Editors: Update this record